Nova Eye Medical (ASX:EYE) EV-to-EBITDA : -6.24 (As of Sep. 24, 2024)

View and export this data going back to 1987. Start your Free Trial

What is Nova Eye Medical EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Nova Eye Medical's enterprise value is A$37.28 Mil. Nova Eye Medical's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 was A$-5.98 Mil. Therefore, Nova Eye Medical's EV-to-EBITDA for today is -6.24.

The historical rank and industry rank for Nova Eye Medical's EV-to-EBITDA or its related term are showing as below:

ASX:EYE' s EV-to-EBITDA Range Over the Past 10 Years
Min: -39.19 Med: -2.65 Max: 99.43
Current: -6.23

During the past 13 years, the highest EV-to-EBITDA of Nova Eye Medical was 99.43. The lowest was -39.19. And the median was -2.65.

ASX:EYE's EV-to-EBITDA is ranked worse than
100% of 482 companies
in the Medical Devices & Instruments industry
Industry Median: 14.585 vs ASX:EYE: -6.23

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-09-24), Nova Eye Medical's stock price is A$0.175. Nova Eye Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was A$-0.043. Therefore, Nova Eye Medical's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.

Nova Eye Medical EV-to-EBITDA Historical Data

The historical data trend for Nova Eye Medical's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nova Eye Medical EV-to-EBITDA Chart

Nova Eye Medical Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

EV-to-EBITDA

Get a 7-Day Free Trial

-0.93

-8.55

-2.65

-4.59

-7.95

Nova Eye Medical Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
EV-to-EBITDA	Get a 7-Day Free Trial															-2.65	-	-4.59	-	-7.95

Competitive Comparison of Nova Eye Medical's EV-to-EBITDA

For the Medical Devices subindustry, Nova Eye Medical's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nova Eye Medical's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nova Eye Medical's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Nova Eye Medical's EV-to-EBITDA falls into.

Nova Eye Medical EV-to-EBITDA Calculation

Nova Eye Medical's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA	=	Enterprise Value (Today)	/	EBITDA (TTM)
	=	37.284	/	-5.979
	=	-6.24

Nova Eye Medical's current Enterprise Value is A$37.28 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Nova Eye Medical's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 was A$-5.98 Mil.

Nova Eye Medical (ASX:EYE) EV-to-EBITDA Explanation

Nova Eye Medical's PE Ratio for today is calculated as:

PE Ratio	=	Share Price (Today)	/	Earnings per Share (Diluted) (TTM)
	=	0.175	/	-0.043
	=	At Loss

Nova Eye Medical's share price for today is A$0.175.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Nova Eye Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was A$-0.043.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Nova Eye Medical EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Nova Eye Medical's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Nova Eye Medical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nova Eye Medical Ltd (ASX:EYE) » Definitions » EV-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

107 Rundle Street, Kent Town, Adelaide, SA, AUS, 5067

Website

https://www.nova-eye.com

Nova Eye Medical Ltd is a medical technology company that develops, manufactures and sells a portfolio of proprietary ophthalmic treatment technologies and devices. Used by eye surgeons globally, these technologies include iTrack minimally invasive glaucoma surgery (MIGS), a consumable surgical device that restores the eye's natural outflow pathway to lower pressure inside the eye and to eliminate patient reliance on anti-glaucoma medications for mild-moderate glaucoma. The company's operating segment include AlphaRET and Glaucoma Surgical Devices, it generates maximum revenue from Glaucoma Surgical Devices. Geographically, it derives a majority of revenue from the United States of America.